Cemiplimab With Fianlimab for Resectable Non-Metastatic Colon Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Regeneron Pharmaceuticals
Related studies linked through entity extraction aliases.
Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma
- Status
- RECRUITING
- Phase
- N/A
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy
- Status
- RECRUITING
- Phase
- PHASE3
A Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults
- Status
- RECRUITING
- Phase
- PHASE3
A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Rutgers University Study of the Genetics of Kidney Disease
- Status
- RECRUITING
- Phase
- N/A
First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease
- Status
- RECRUITING
- Phase
- PHASE1
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
- Status
- RECRUITING
- Phase
- PHASE3
A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
- Status
- RECRUITING
- Phase
- PHASE2
A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Growth and Bone Mineral Density in Children With Atopic Dermatitis (AD) Treated With Dupilumab
- Status
- WITHDRAWN
- Phase
- PHASE4
Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Test the Safety of Pozelimab in Pediatric Participants 1 to 5 Years of Age With a Rare Disease Called CHAPLE (Complement Hyperactivation, Angiopathic Thrombosis, Protein-losing Enteropathy) Disease
- Status
- RECRUITING
- Phase
- PHASE4
Odronextamab in Low Tumor Volume Advanced FL
- Status
- RECRUITING
- Phase
- PHASE2